Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for ...

Investing.com -- The US Food and Drug Administration has accepted GlaxoSmithKline (NYSE: GSK )’s biologics license ...

The Indian stock market faces pressure from foreign capital outflow and economic weakness, with Nifty 50 down 15.82% since ...

Global survey reveals limited awareness of shingles among adults over 50, highlighting age-related health risks and complications.

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...

The NCSD Speakers Bureau Roster features nearly 250 public speakers, celebrities, cancer survivors, and medical professionals eligible to ...

The demand for this year’s Oscars is an undeniable reflection of the show’s evergreen cultural influence, and a testament to ...

Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.

FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

New data shows Australia's gender pay gap has narrowed, but working women are still more than $28,000 a year worse off than ...